N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide

C91H113F2N25O7 — CID 163502094

IUPACN-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12
InChIInChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23)
InChIKeyCVPWQYJJFIMKMT-UHFFFAOYSA-N
MW1707.07 g/mol
LogP11.76
Rot. Bonds22

About N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide

N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 163502094) has the molecular formula C91H113F2N25O7 and a molecular weight of 1707.07 g/mol. Its IUPAC name is N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID163502094
Molecular FormulaC91H113F2N25O7
Molecular Weight1707.07 g/mol
Exact Mass1705.92
IUPAC NameN-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12
InChIInChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23)
InChIKeyCVPWQYJJFIMKMT-UHFFFAOYSA-N
XLogP11.76
TPSA350.41 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds22
Heavy Atoms125
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001707.07
LogP ≤ 511.76
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Analyze N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[4-[[5-[4-Methyl-6-[[4-(trifluoromethyl)-2-pyridinyl]amino]-2-pyridinyl]-2-pyridinyl]amino]piperidin-1-yl]-pyrazolo[1,5-a]pyrimidin-3-ylmethanone
CID 119098962
N-[(1R,2S)-2-fluorocyclopropyl]-7-(methylamino)-5-[1-[(3S)-oxolan-3-yl]pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449895
N-[(1R,2S)-2-fluorocyclopropyl]-7-(methylamino)-5-[1-[(3R)-oxolan-3-yl]pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449905
N-[(1S,2R)-2-fluorocyclopropyl]-7-(methylamino)-5-[1-(2-morpholin-4-ylethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449906
N-[(1S,2R)-2-fluorocyclopropyl]-7-(methylamino)-5-[1-(oxolan-3-yl)pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 146383307
N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-5-[2-(5-fluoro-2-methyl-3-pyridinyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 68913117
N-[(1S,2R)-2-fluorocyclopropyl]-7-(methylamino)-5-(3-morpholin-4-ylpyrrolo[3,2-b]pyridin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449181
N-[(1S,2R)-2-fluorocyclopropyl]-7-(methylamino)-5-[1-(2-morpholin-4-ylethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 146383372
N-cyclopropyl-7-(methylamino)-5-[1-(oxolan-3-yl)pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449381
N-cyclopropyl-7-(methylamino)-5-[1-(2-morpholin-4-ylethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137457885
N-cyclopropyl-7-(methylamino)-5-[1-(2-morpholin-4-ylethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CID 137449379
US20240368194, Example 62
CID 167440018

Frequently Asked Questions

What is the IUPAC name of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 163502094) is N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is CCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12.
What is the InChIKey of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is CVPWQYJJFIMKMT-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23).
What are the key properties of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 1707.07 g/mol, XLogP of 11.76, 22 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 163502094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).